ACAD
Acadia Pharmaceuticals Inc

13,121
Mkt Cap
$4.49B
Volume
2.12M
52W High
$27.61
52W Low
$13.40
PE Ratio
17.65
ACAD Fundamentals
Price
$27.44
Prev Close
$26.55
Open
$26.75
50D MA
$22.64
Beta
0.96
Avg. Volume
1.6M
EPS (Annual)
$1.36
P/B
5.06
Rev/Employee
$1.46M
Loading...
Loading...
News
all
press releases
ACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 12-Month High - Should You Buy?
ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year High - Time to Buy...
MarketBeat·3h ago
News Placeholder
More News
News Placeholder
Why Is Acadia (ACAD) Up 22.6% Since Last Earnings Report?
Acadia (ACAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·9h ago
News Placeholder
Stonepine Capital Management LLC Has $4.85 Million Stake in ACADIA Pharmaceuticals Inc. $ACAD
Stonepine Capital Management LLC raised its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 140.9% during the second quarter, according to the company in its most recent 13F...
MarketBeat·13h ago
News Placeholder
Stonepine Capital Management LLC Has $4.85 Million Stake in ACADIA Pharmaceuticals Inc. $ACAD
Stonepine Capital Management LLC raised its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 140.9% during the second quarter, according to the company in its most recent 13F...
MarketBeat·13h ago
News Placeholder
Edgestream Partners L.P. Sells 47,964 Shares of ACADIA Pharmaceuticals Inc. $ACAD
Edgestream Partners L.P. reduced its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 30.1% in the second quarter, according to its most recent filing with the SEC...
MarketBeat·17h ago
News Placeholder
Fisher Asset Management LLC Sells 44,710 Shares of ACADIA Pharmaceuticals Inc. $ACAD
Fisher Asset Management LLC decreased its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 12.6% in the second quarter, according to the company in its most recent 13F...
MarketBeat·17h ago
News Placeholder
Acadia Stock Up 59% in a Year Is a $51 Million New Stake a Bet on a Bigger Rebound?
Key PointsConnecticut-based fund Braidwell bought 2,378,655 shares of Acadia Pharmaceuticals in the third quarter, representing a new position valued at about $50.8 million as of September 30...
Nasdaq News: Markets·2d ago
News Placeholder
F m Investments LLC Lowers Position in ACADIA Pharmaceuticals Inc. $ACAD
F m Investments LLC decreased its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 29.5% during the second quarter, according to its most recent 13F filing with the...
MarketBeat·5d ago
News Placeholder
Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·7d ago
News Placeholder
Prudential Financial Inc. Raises Stock Holdings in ACADIA Pharmaceuticals Inc. $ACAD
Prudential Financial Inc. increased its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 93.3% in the second quarter, according to its most recent filing with the SEC...
MarketBeat·8d ago

Latest ACAD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.